Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05355974 · ClinicalTrials.gov registry record · Phase 3
Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure
A Phase 3 study, sponsored by Wright State University.
- Completed
- Registry status
- Phase 3
- Development phase
- 42
- Enrollment target
NCT05355974: Completed Phase 3 study, sponsored by Wright State University.
NCT05355974 is a Phase 3 study that has completed, run by Wright State University. The registered enrollment target is 42 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05355974, a Phase 3 study, has completed, sponsored by Wright State University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether protocolized vasopressor use for patients with normal blood pressure undergoing rapid sequence intubation improves hemodynamic parameters and mitigates adverse events. The hypothesis is that use of vasopressors during Rapid Sequence Intubation will prevent substantial decreases in blood pressure when compared to normal intravenous fluids.
Primary Outcome
Change in systolic blood pressure during rapid sequence intubation in mmHg.
Interventions
- DRUG Norepinephrine
- DRUG normal saline
- DRUG Lactated Ringers, Intravenous
- DRUG Plasma-lyte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2022-08-09 |
| Est. Completion | 2024-07-10 |
| Phase | Phase 3 |
What the finished NCT05355974 record still lists
NCT05355974 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which Norepinephrine is the first listed.
NCT05355974 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05355974 about?
NCT05355974 is a clinical study titled "Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure". The purpose of this study is to investigate whether protocolized vasopressor use for patients with normal blood pressure undergoing rapid sequence intubation improves hemodynamic parameters and mitigates adverse events. The hypothesis is that use of vasopressors during Rapid Sequence Intubation wil...
What is the current status of trial NCT05355974?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 42 participants. The study started on 2022-08-09. Estimated completion is 2024-07-10.
What interventions are being tested in trial NCT05355974?
The interventions under investigation include: Norepinephrine (DRUG), normal saline (DRUG), Lactated Ringers, Intravenous (DRUG), Plasma-lyte (DRUG).
Who is sponsoring clinical trial NCT05355974?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05355974's enrollment target sits among peer trials
42 1877th of 2000 higher than 124 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI